Loading...

RadNet, Inc.

RDNTNASDAQ
Healthcare
Medical - Diagnostics & Research
$70.10
$1.49(2.17%)

RadNet, Inc. (RDNT) Stock Overview

Explore RadNet, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.1/100

Key Financials

Market Cap5.4B
P/E Ratio-347.93
EPS (TTM)$-0.20
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Week$56.10
1 Month$54.57
3 Months$66.59
1 Year Target$106.77

RDNT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RadNet, Inc. (RDNT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $106.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -347.93 and a market capitalization of 5.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;